Gastrotsepin is an anti-ulcer, reducing acid production, gastroprotective (film-forming) agent M1 cholinergic receptor blocker.
The active substance gastrotsepin - pirenzepine, which is a selective antagonist of M1-cholinergic receptors localized in parasympathetic nodes of the alimentary canal. Non-selective anticholinergic blocking M1 and M2 cholinergic receptors, not only to reduce the secretion of gastric glands, but also bronchial and salivary glands contribute dilated pupils, increased heart rate, lowering the tone of smooth muscles.
Gastrotsepin as selective anticholinergic, no side effects and is effective directions: reducing emissions of pepsinogen (proenzyme), reduces acid secretion, regulates the motility of the digestive tract, increases the pH level, improves blood flow to the gastric mucosa. The efficacy in the treatment of diseases of the duodenum and pancreas confirmed by therapeutic practice and feedback gastrotsepin.
The advisability of administering the drug gastrotsepin, instruction confirms is at:
- treatment and prevention of peptic ulcer disease;
- duodenitis (inflammation of the duodenum);
- erosive and ulcerative lesions of the gastrointestinal tract, including those caused by anti-inflammatory and anti-rheumatic drugs;
- Zollinger-Ellison syndrome (peptic ulcers of the stomach and duodenum, persistent diarrhea provoked by tumor);
- stress ulcers of the gastrointestinal tract;
- bleeding from ulcers and erosions of the upper gastrointestinal tract.
Instructions for use gastrotsepin
Gastrotsepin produced in the form of tablets of 25 or 50 mg and as a solution for injection (2 ml corresponds to 10 mg).
A oral daily dose, according to the instructions gastrotsepina is 50-150 mg. Usually tablets taken twice a day for 30 minutes before a meal to 50 mg. The treatment should not be less than 4-6 weeks, even
with a subjective improvement.
Intravenous and intramuscular gastrotsepin usually administered in the first 2-3 days of therapy to clinical improvement, then the patient is transferred to the pills. Parenteral (bypassing the gastrointestinal tract) therapy involves administration of 1 ampoule (2 ml) of the drug every 12 hours, and at the stressful ulcer - every 8 hours.
For intravenous injection solution gastrotsepin diluted in 5% solution of glucose re p re-Ringer, 5% solution in D levulose or isotonic p-re of sodium chloride.
Guide to the drug gastrotsepin, patient testimonials and clinical studies have warned that the use of this drug may be: tachycardia, dry mouth, urinary retention, constipation, diarrhea, hypersensitivity, anaphylactic reactions, headache.
According to the instructions, gastrotsepin not administered to children, patients with paralytic ileus, and persons with hypersensitivity to pirenzepine.
Gastrotsepin by injection is contraindicated in pregnant and lactating women, as well as tablets - Patients with galactose intolerance and the violation of the absorbability of galactose and glucose.
Instruction gastrotsepin recommends storing injection at a temperature not exceeding 25
C and the tablet - not exceeding 30